Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Market Cap	29.66B
Revenue (ttm)	2.07B
Net Income (ttm)	-1.36B
Shares Out	984.87M
EPS (ttm)	-1.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,807,000
Average Volume	2,063,274
Open	16.64
Previous Close	16.78
Day's Range	15.74 - 17.26
52-Week Range	9.17 - 21.70
Beta	0.46
RSI	67.53
Earnings Date	Mar 28, 2025

About HKG:1877

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,578
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1877

Financial Performance

In 2024, HKG:1877's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.84% less than in 2023.

Financial numbers in CNY